Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD

Abstract Chronic obstructive pulmonary disease (COPD) treatment guidelines do not currently include recommendations for escalation directly from monotherapy to triple therapy. This 12-week, double-blind, double-dummy study randomized 800 symptomatic moderate-to-very-severe COPD patients receiving ti...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sandeep Bansal, Martin Anderson, Antonio Anzueto, Nicola Brown, Chris Compton, Thomas C. Corbridge, David Erb, Catherine Harvey, Morrys C. Kaisermann, Mitchell Kaye, David A. Lipson, Neil Martin, Chang-Qing Zhu, Alberto Papi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2021-05-01
coleção:	npj Primary Care Respiratory Medicine
Acesso em linha:	https://doi.org/10.1038/s41533-021-00241-z
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!